细胞外囊泡与肝脏疾病发生发展的关系

王江瑜; 王志鑫; 樊海宁

doi:10.3969/j.issn.1001-5256.2018.03.048

细胞外囊泡与肝脏疾病发生发展的关系

DOI: 10.3969/j.issn.1001-5256.2018.03.048

1. 青海大学
2. 青海大学附属医院肝胆胰外科
3. 青海省包虫病重点实验室

基金项目:

青海省人畜包虫病防控策略与创新技术应用(2016-SF-A5)；

详细信息

中图分类号: R575
计量
- 文章访问数: 2312
- HTML全文浏览量: 18
- PDF下载量: 454
- 被引次数: 0
出版历程
- 出版日期: 2018-03-20

Role of extracellular vesicles in the development and progression of liver diseases

Qinghai University

Research funding:

摘要

摘要: 细胞外囊泡(EV)是细胞释放到细胞外环境中的膜结合小泡,能够选择性地富集特定蛋白和RNA,介导细胞间通讯。因此,EV具有作为疾病的生物标志物、治疗靶标和传递载体的潜力。总结了EV在病毒性肝炎、肝纤维化和肝癌中的研究进展,探讨其在肝脏疾病中所发挥的作用,以强调EV在未来肝脏疾病研究中的应用前景。
- 细胞外囊泡 /
- 肝炎,病毒性,人 /
- 肝硬化 /
- 肝肿瘤 /
- 综述
Abstract: Extracellular vesicles ( EVs) are membrane-bound vesicles released by cells into the extracellular environment and can selectively enrich specific proteins and RNA and mediate intercellular communication. Therefore, EVs have the potential of a biomarker for diseases, a therapeutic target, and a delivery vector. This article reviews the research advances in the role of EVs in viral hepatitis, liver fibrosis, and liver cancer and emphasizes the prospects of EVs in liver diseases.
- extracellular vesicles /
- hepatitis, viral, human /
- liver cirrhosis /
- liver cancers /
- liver neoplasms

HTML全文

参考文献(45)

[1]PAN BT, JOHNSTONE RM.Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro:selective externalization of the receptor[J].Cell, 1983, 33 (3) :967-978.

[2]OGAWA Y, KANAI-AZUMA M, AKIMOTO Y, et al.Exosome-like vesicles with dipeptidyl peptidase IV in human saliva[J].Biol Pharm Bull, 2008, 31 (6) :1059-1062.

[3]JOHNSTONE RM, ADAM M, HAMMOND JR, et al.Vesicle formation during reticulocyte maturation.Association of plasma membrane activities with released vesicles (exosomes) [J].J Biol Chem, 1987, 262 (19) :9412-9420.

[4]TKACH M, THERY C.Communication by extracellular vesicles:where we are and where we need to go[J].Cell, 2016, 164 (6) :1226-1232.

[5]SZABO G, MOMEN-HERAVI F.Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (8) :455-466.

[6]BUSCA A, KUMAR A.Innate immune responses in hepatitis B virus (HBV) infection[J].Virol J, 2014, 11:22.

[7]KOUWAKI T, FUKUSHIMA Y, DAITO T, et al.Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection[J].Front Immunol, 2016, 7:335.

[8]LI J, LIU K, LIU Y, et al.Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity[J].Nat Immunol, 2013, 14 (8) :793-803.

[9]YANG Y, HAN Q, HOU Z, et al.Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction[J].Cell Mol Immunol, 2017, 14 (5) :465-475.

[10]COBB DA, KIM OK, GOLDEN-MASON L, et al.Hepatocytederived exosomes promote T follicular regulatory cell expansion during hepatitis C virus infection[J].Hepatology, 2018, 67 (1) :71-85.

[11]MASCIOPINTO F, GIOVANI C, CAMPAGNOLI S, et al.Association of hepatitis C virus envelope proteins with exosomes[J].Eur J Immunol, 2004, 34 (10) :2834-2842.

[12]BUKONG TN, MOMEN-HERAVI F, KODYS K, et al.Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90[J].PLo S Pathog, 2014, 10 (10) :e1004424.

[13]ROBBINS PD, MORELLI AE.Regulation of immune responses by extracellular vesicles[J].Nat Rev Immunol, 2014, 14 (3) :195-208.

[14]ZHOU Y, WANG X, SUN L, et al.Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes[J].FASEB J, 2016, 30 (12) :4132-4140.

[15]SHRIVASTAVA S, RAYCHOUDHURI A, STEELE R, et al.Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes[J].Hepatology, 2011, 53 (2) :406-414.

[16]SHRIVASTAVA S, DEVHARE P, SUJIJANTARAT N, et al.Knockdown of autophagy inhibits infectious hepatitis C virus release by the exosomal pathway[J].J Virol, 2015, 90 (3) :1387-1396.

[17]WANG R, DING Q, YAQOOB U, et al.Exosome adherence and internalization by hepatic stellate cells triggers sphingosine 1-phosphate-dependent migration[J].J Biol Chem, 2015, 290 (52) :30684-30696.

[18]FABREGAT I, MORENO-CACERES J, SANCHEZ A, et al.TGF-βsignalling and liver disease[J].FEBS J, 2016, 283 (12) :2219-2232.

[19]WALLACE MC, FRIEDMAN SL, MANN DA.Emerging and disease-specific mechanisms of hepatic stellate cell activation[J].Semin Liver Dis, 2015, 35 (2) :107-118.

[20]RAMADORI G, SAILE B.Mesenchymal cells in the liver——one cell type or two?[J].Liver, 2002, 22 (4) :283-294.

[21]GRESSNER OA, LAHME B, DEMIRCI I, et al.Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes[J].J Hepatol, 2007, 47 (5) :699-710.

[22]CHEN L, CHARRIER A, ZHOU Y, et al.Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells[J].Hepatology, 2014, 59 (3) :1118-1129.

[23]CHEN L, CHEN R, KEMPER S, et al.Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression:role of exosomes in horizontal transfer of Twist1[J].Am J Physiol Gastrointest Liver Physiol, 2015, 309 (6) :g491-g499.

[24]KORNEK M, POPOV Y, LIBERMANN TA, et al.Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells[J].Hepatology, 2011, 53 (1) :230-242.

[25]SEO W, EUN HS, KIM SY, et al.Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17production byγδT cells in liver fibrosis[J].Hepatology, 2016, 64 (2) :616-631.

[26]QU Y, ZHANG Q, CAI X, et al.Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J].J Cell Mol Med, 2017, 21 (10) :2491-2502.

[27]BOVY N, BLOMME B, FRèRES P, et al.Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer[J].Oncotarget, 2015, 6 (12) :10253-10266.

[28]KOGURE T, LIN WL, YAN IK, et al.Intercellular nanovesiclemediated microRNA transfer:a mechanism of environmental modulation of hepatocellular cancer cell growth[J].Hepatology, 2011, 54 (4) :1237-1248.

[29]WEI JX, LV LH, WAN YL, et al.Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells[J].Hepatology, 2015, 61 (4) :1284-1294.

[30]CONIGLIARO A, COSTA V, LO DICO A, et al.CD90+liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J].Mol Cancer, 2015, 14:155.

[31]MAJI S, MATSUDA A, YAN IK, et al.Extracellular vesicles in liver diseases[J].Am J Physiol Gastrointest Liver Physiol, 2017, 312 (3) :g194-g200.

[32] HOSHINO A, COSTA-SILVA B, SHEN TL, et al.Tumour exosome integrins determine organotropic metastasis[J].Nature, 2015, 527 (7578) :329-335.

[33]LUGINI L, CECCHETTI S, HUBER V, et al.Immune surveillance properties of human NK cell-derived exosomes[J].J Immunol, 2012, 189 (6) :2833-2842.

[34]KO SF, YIP HK, ZHEN YY, et al.Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model:apparent diffusion coefficient, natural killer t-cell responses, and histopathological features[J].Stem Cells Int, 2015, 2015:853506.

[35]TAMURA Y, PENG P, LIU K, et al.Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations[J].Science, 1997, 278 (5335) :117-120.

[36]LV LH, WAN YL, LIN Y, et al.Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro[J].J Biol Chem, 2012, 287 (19) :15874-15885.

[37]POCKLEY AG.Heat shock proteins as regulators of the immune response[J].Lancet, 2003, 362 (9382) :469-476.

[38]MOROISHI T, HAYASHI T, PAN WW, et al.The Hippo pathway kinases LATS1/2 suppress cancer immunity[J].Cell, 2016, 167 (6) :1525-1539.

[39]SUGIMACHI K, MATSUMURA T, HIRATA H, et al.Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation[J].Br J Cancer, 2015, 112 (3) :532-538.

[40]SOHN W, KIM J, KANG SH, et al.Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma[J].Exp Mol Med, 2015, 47:e184.

[41]WANG H, HOU L, LI A, et al.Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma[J].Biomed Res Int, 2014, 2014:864894.

[42]BRODSKY SV, FACCIUTO ME, HEYDT D, et al.Dynamics of circulating microparticles in liver transplant patients[J].J Gastrointestin Liver Dis, 2008, 17 (3) :261-268.

[43]COSTA-SILVA B, AIELLO NM, OCEAN AJ, et al.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J].Nat Cell Biol, 2015, 17 (6) :816-826.

[44]WANG X, DING X, NAN L, et al.Investigation of the roles of exosomes in colorectal cancer liver metastasis[J].Oncol Rep, 2015, 33 (5) :2445-2453.

[45]CHIBA M, KIMURA M, ASARI S.Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma Hep G2and lung cancer A549 cell lines[J].Oncol Rep, 2012, 28 (5) :1551-1558.

施引文献

资源附件(0)

访问统计